Guidelines for Submission
- All abstracts are subject to review by the Scientific Program Committee.
- Abstracts must be submitted according to guidelines given below.
- Abstracts should be prepared and submitted as a Word document to via abstract login.
- Please use ‘Calibri’ font. The font size should be 11 points or bigger.
Preferred presentation type should be clearly mention.
- Oral Presentation will be in physical mode
- Poster Presentation will be virtual /physical
However, the scientific committee reserves the right to accept/ reject/ assign a different presentation type to all the abstracts submitted.
Abstract Title
- Please write the title in UPPER CASE and should be limited to 30 words.
- Leave one blank line between the title and authors/ affiliations.
Abstract Text
- Abstract should be limited to 500 words including acknowledgements (if any).
- The abstract may include one table or graph or picture.
- Abstracts that merely state the results which will be presented, will be subject to rejection.
- Abstracts should clearly state the following;
- Background and Aims
- Methods
- Results
- Conclusions
- Use only standard abbreviations. Abbreviations must be consistent and be defined on 1st usage, then use of abbreviation.
- Use generic names of drugs (if any). The presentation must be balanced and contain no commercial promotional content.
- Do not begin sentences with a number – type the number in full, for example, it should be ‘Three patients….’ Instead of ‘3 patients….’.
- An acknowledgment with an identification (unique) number shall be shared with you on receipt of your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
- Please contact us if you have not received confirmation that your abstract has been submitted.
- Please do not submit multiple copies of the same abstract.
- If the application is not sent in the prescribed format (as mentioned above), it will not be considered for review.